Application of liposomes in treatment of rheumatoid arthritis: quo vadis

about

Synovial fibroblast-targeting liposomes encapsulating an NF-κB-blocking peptide ameliorates zymosan-induced synovial inflammation.Lipid-Based Nanoparticles as a Potential Delivery Approach in the Treatment of Rheumatoid Arthritis.Intra-articular drug delivery systems for joint diseases.

P2860

Q48136052-9F8519E0-A298-44B0-AE51-3B01099601FB Q48225327-1D690F17-62B5-40C1-8662-931516128CD5 Q52721095-AF2C8EB2-BCBC-40DC-A35B-619173D1A79E

P2860

Application of liposomes in treatment of rheumatoid arthritis: quo vadis

Item

http://www.wikidata.org/entity/Q59101195

description

im Februar 2014 veröffentlichter wissenschaftlicher Artikel

@de

scientific article published on 04 February 2014

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована в лютому 2014

@uk

name

Application of liposomes in treatment of rheumatoid arthritis: quo vadis

@en

Application of liposomes in treatment of rheumatoid arthritis: quo vadis

@nl

type

Item

label

Application of liposomes in treatment of rheumatoid arthritis: quo vadis

@en

Application of liposomes in treatment of rheumatoid arthritis: quo vadis

@nl

prefLabel

Application of liposomes in treatment of rheumatoid arthritis: quo vadis

@en

Application of liposomes in treatment of rheumatoid arthritis: quo vadis

@nl

P1476

Application of liposomes in treatment of rheumatoid arthritis: quo vadis

@en

P2093

Monica Gulati

http://www.w3.org/2001/XMLSchema#string

Sachin Kumar Singh

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 3.0 Unported

P2860

Structure of curcumin in complex with lipoxygenase and its significance in cancer

Development of macromolecular prodrug for rheumatoid arthritis

Liposome-incorporated corticosteroids: I. The interaction of liposomal cortisol palmitate with inflammatory synovial membrane

Liposome-incorporated corticosteroids. II. Therapeutic activity in experimental arthritis

Separating therapeutic efficacy from glucocorticoid side-effects in rodent arthritis using novel, liposomal delivery of dexamethasone phosphate: long-term suppression of arthritis facilitates interval treatment

Superoxide dismutase entrapped in long-circulating liposomes: formulation design and therapeutic activity in rat adjuvant arthritis.

The use of leflunomide in the treatment of rheumatoid arthritis: an experimental and clinical review.

Leflunomide: an immunomodulatory drug for the treatment of rheumatoid arthritis and other autoimmune diseases.

Pattern and predictors of the initiation of biologic agents for the treatment of rheumatoid arthritis in the United States: an analysis using a large observational data bank.

Prednisolone-loaded PLGA microspheres. in vitro characterization and in vivo application in adjuvant-induced arthritis in mice.

P304

978351

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2014/978351

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

2014

http://www.w3.org/2001/XMLSchema#string

P50

Bhupinder Kapoor

Reena Gupta

Yogyata Vaidya

P5008

ScienceSource

P577

2014-02-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24688450

http://www.w3.org/2001/XMLSchema#string

P921

rheumatoid arthritis

P932

3932268

http://www.w3.org/2001/XMLSchema#string

Application of liposomes in treatment of rheumatoid arthritis: quo vadis

about

P2860

P2860

Application of liposomes in treatment of rheumatoid arthritis: quo vadis

description

name

type

label

prefLabel

P1433

P1476

P2093

P275

P2860

P304

P31

P356

P407

P478

P50

P5008

P577

P698

P921

P932

P356

P1433

P1476

P2093

P275

P2860

P304

P31

P356

P407

P478

P50

P5008

P577

P698

P921

P932